• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在所有类风湿性关节炎患者及数据库中,是否都应评估比肿胀或压痛更常见的关节畸形?

Should Joint Deformity, which is More Common Than Swelling or Tenderness, be Assessed in all Rheumatoid Arthritis Patients and Databases?

作者信息

Pincus Theodore, Li Tengfei, Gibson Kathryn A

机构信息

Rush University Medical Center, Chicago, Illinois.

Liverpool Hospital and Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia, and University of New South Wales, Medicine and Health, Sydney, New South Wales, Australia.

出版信息

ACR Open Rheumatol. 2025 May;7(5):e70025. doi: 10.1002/acr2.70025.

DOI:10.1002/acr2.70025
PMID:40390367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12089699/
Abstract

OBJECTIVE

We analyzed 28 joint counts in 173 contemporary routine care patients with rheumatoid arthritis (RA), who had disease duration of 10 years and were examined in 2021, for swollen joint count (SJC), tender joint count (TJC)/pain on motion, and deformity joint count (DJC)/limited motion. In addition, we computed DJC according to Disease Activity Score in 28 joints (DA28), Clinical Disease Activity Index (CDAI), and Routine Assessment of Patient Index Data 3 (RAPID3) as remission/low or moderate/high activity or severity.

METHODS

This report presents a retrospective analyses of a cross-sectional Australian database for medians and prevalences of SJC, TJC, and DJC, including in RA index categories.

RESULTS

Median values were 0 for SJC, 2.0 for TJC, and 4.0 for DJC, respectively, including SJC of 0,1 in 123 patients (71%), TJC of 0,1 in 82 patients (47%), SJC+TJC of 0,1 in 73 patients (42%), and DJC of 0,1 in 65 patients (38%). Among 4,498 joints, 1,330 with any abnormality included 286 swollen joints (6%), 590 tender joints (13%), 879 deformed joints (20%), 37 only swollen joints (1%), 289 only tender joints (6%), 659 only deformed joints (15%), 458 joints with two abnormalities (10%), and 80 joints with three abnormalities (2%). The 73 of all 173 with patients with SJC and TJC 0,1 (42%), included 56% to 67% who were classified in remission or low DAS28 ESR erythrocyte sedimentation rate, CDAI, or RAPID3 activity or severity, of whom 47% to 58% had DJC ≥2, whereas 11% to 36% were classified as moderate or high RA index activity or severity, of whom 57% to 58% had DJC ≥2.

CONCLUSION

SJC+TJC of 0,1 was more common than a DJC of 0,1 in contemporary patients with RA. DJC was ≥2 in the majority of patients who met SJC+TJC remission criteria for RA indices, as in patients who were classified as moderate/high although they met SJC+TJC remission criteria. DJC should be included in long-term routine care and RA databases.

摘要

目的

我们分析了173例病程达10年且于2021年接受检查的当代类风湿关节炎(RA)常规护理患者的28个关节计数,以了解肿胀关节计数(SJC)、压痛关节计数(TJC)/活动时疼痛情况以及畸形关节计数(DJC)/活动受限情况。此外,我们根据28个关节疾病活动评分(DA28)、临床疾病活动指数(CDAI)和患者指数数据3常规评估(RAPID3)计算DJC,以确定缓解/低或中度/高活动度或严重程度。

方法

本报告对一个澳大利亚横断面数据库进行回顾性分析,以获取SJC、TJC和DJC的中位数及患病率,包括RA指数类别中的数据。

结果

SJC的中位数为0,TJC为2.0,DJC为4.0,其中123例患者(71%)的SJC为0或1,82例患者(47%)的TJC为0或1,73例患者(42%)的SJC + TJC为0或1,65例患者(38%)的DJC为0或1。在4498个关节中,1330个有任何异常,包括286个肿胀关节(6%)、590个压痛关节(13%)、879个畸形关节(20%)、37个仅肿胀关节(1%)、289个仅压痛关节(6%)、659个仅畸形关节(15%)、458个有两种异常的关节(10%)和80个有三种异常的关节(2%)。173例患者中SJC和TJC为0或1的73例(42%),包括56%至67%被分类为缓解或低DAS28(红细胞沉降率)、CDAI或RAPID3活动度或严重程度的患者,其中47%至58%的患者DJC≥2,而11%至36%被分类为中度或高度RA指数活动度或严重程度的患者,其中57%至58%的患者DJC≥2。

结论

在当代RA患者中,SJC + TJC为0或1比DJC为0或1更常见。在符合RA指数SJC + TJC缓解标准的大多数患者中,DJC≥2,在符合SJC + TJC缓解标准但被分类为中度/高度的患者中也是如此。DJC应纳入长期常规护理和RA数据库。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/12089699/830f9c207c6a/ACR2-7-e70025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/12089699/830f9c207c6a/ACR2-7-e70025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e54/12089699/830f9c207c6a/ACR2-7-e70025-g001.jpg

相似文献

1
Should Joint Deformity, which is More Common Than Swelling or Tenderness, be Assessed in all Rheumatoid Arthritis Patients and Databases?在所有类风湿性关节炎患者及数据库中,是否都应评估比肿胀或压痛更常见的关节畸形?
ACR Open Rheumatol. 2025 May;7(5):e70025. doi: 10.1002/acr2.70025.
2
Physician estimate of inflammation global assessment in explaining variations in swollen joint counts in rheumatoid arthritis patients.医生对炎症的评估:类风湿关节炎患者肿胀关节计数变化的整体评估解释。
Rheumatol Adv Pract. 2024 Apr 27;8(2):rkae057. doi: 10.1093/rap/rkae057. eCollection 2024.
3
Elevated DAS28-ESR in patients with rheumatoid arthritis who have comorbid fibromyalgia is associated more with tender joint counts than with patient global assessment or swollen joint counts: implications for assessment of inflammatory activity.患有纤维肌痛的类风湿关节炎患者的 DAS28-ESR 升高与压痛关节计数的相关性高于患者总体评估或肿胀关节计数,提示其对炎症活动的评估具有重要意义。
Clin Exp Rheumatol. 2024 May;42(5):1083-1090. doi: 10.55563/clinexprheumatol/vfvso2. Epub 2024 Mar 22.
4
Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis.28关节疾病活动评分作为测量早期类风湿关节炎患者疾病活动度的工具。
J Rheumatol. 2007 Oct;34(10):1987-91. Epub 2007 Jul 1.
5
Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.患者索引数据3的常规评估以及美国风湿病学会/欧洲抗风湿病联盟临时缓解定义作为托珠单抗类风湿关节炎临床试验中影像学结果的预测指标
Arthritis Care Res (Hoboken). 2017 May;69(5):609-615. doi: 10.1002/acr.23008. Epub 2017 Apr 7.
6
Can a simple 0-10 RheuMetric physician estimate of inflammatory activity (DOCINF) depict a detailed swollen joint count (SJC) as accurately as a DAS28 or CDAI in patients with rheumatoid arthritis?在类风湿关节炎患者中,医生简单的 0-10 RheuMetric 炎症活动度评估(DOCINF)能否像 DAS28 或 CDAI 一样准确地描述详细的肿胀关节计数(SJC)?
Semin Arthritis Rheum. 2024 Oct;68:152485. doi: 10.1016/j.semarthrit.2024.152485. Epub 2024 Jun 22.
7
Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.在临床实践中,仅常规评估患者指数数据 3(RAPID3)不足以监测类风湿关节炎的疾病活动度。
RMD Open. 2019 Nov 28;5(2):e001050. doi: 10.1136/rmdopen-2019-001050. eCollection 2019.
8
Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?类风湿关节炎患者接受抗肿瘤坏死因子-α治疗后的短期疗效:我们是否需要修订评估标准?
J Rheumatol. 2006 Mar;33(3):490-7.
9
A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis.一项多中心观察性研究,比较患者报告的结果,以评估类风湿关节炎中肿胀和压痛关节评估的可靠性以及与临床医生评估相比的赛妥珠单抗治疗反应。
Int J Rheum Dis. 2019 Jan;22(1):73-80. doi: 10.1111/1756-185X.13364. Epub 2018 Sep 5.
10
Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis.不要只关注 28 个关节疾病活动评分(DAS28):压痛点数会影响类风湿关节炎患者的 DAS28。
J Rheumatol. 2012 Jan;39(1):22-7. doi: 10.3899/jrheum.110072. Epub 2011 Oct 15.

本文引用的文献

1
Can a simple 0-10 RheuMetric physician estimate of inflammatory activity (DOCINF) depict a detailed swollen joint count (SJC) as accurately as a DAS28 or CDAI in patients with rheumatoid arthritis?在类风湿关节炎患者中,医生简单的 0-10 RheuMetric 炎症活动度评估(DOCINF)能否像 DAS28 或 CDAI 一样准确地描述详细的肿胀关节计数(SJC)?
Semin Arthritis Rheum. 2024 Oct;68:152485. doi: 10.1016/j.semarthrit.2024.152485. Epub 2024 Jun 22.
2
Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry.利妥昔单抗治疗类风湿关节炎的临床试验中的疗效和安全性数据能否外推?来自AIR-PR注册研究中1984例患者的见解。
Rheumatology (Oxford). 2024 Jul 1;63(7):1893-1901. doi: 10.1093/rheumatology/kead495.
3
RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference Measures.类风湿关节炎中炎症、损伤和痛苦的RheuMetric定量0至10分医生评估:与参考指标的验证
ACR Open Rheumatol. 2023 Oct;5(10):511-521. doi: 10.1002/acr2.11574. Epub 2023 Aug 22.
4
American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision.美国风湿病学会/欧洲抗风湿病联盟类风湿关节炎缓解标准:2022 年修订版。
Arthritis Rheumatol. 2023 Jan;75(1):15-22. doi: 10.1002/art.42347. Epub 2022 Oct 23.
5
Satisfaction With a Virtual Learning Collaborative Aimed at Implementing Treat-to-Target in Rheumatoid Arthritis.类风湿关节炎达标治疗虚拟学习协作的满意度。
J Clin Rheumatol. 2022 Aug 1;28(5):265-269. doi: 10.1097/RHU.0000000000001851. Epub 2022 May 24.
6
Implementing a Treat-to-Target Approach for Rheumatoid Arthritis During the COVID-19 Pandemic: Results of a Virtual Learning Collaborative Program.在 COVID-19 大流行期间实施类风湿关节炎的达标治疗方法:虚拟学习协作计划的结果。
Arthritis Care Res (Hoboken). 2022 Apr;74(4):572-578. doi: 10.1002/acr.24830. Epub 2022 Feb 4.
7
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.2021年美国风湿病学会类风湿关节炎治疗指南
Arthritis Rheumatol. 2021 Jul;73(7):1108-1123. doi: 10.1002/art.41752. Epub 2021 Jun 8.
8
The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies.临床疾病活动指数和用于评估治疗策略达成情况的患者指数数据3常规评估
J Rheumatol. 2021 Dec;48(12):1776-1783. doi: 10.3899/jrheum.200692. Epub 2020 Dec 15.
9
EULAR definition of difficult-to-treat rheumatoid arthritis.EULAR 定义的难治性类风湿关节炎。
Ann Rheum Dis. 2021 Jan;80(1):31-35. doi: 10.1136/annrheumdis-2020-217344. Epub 2020 Oct 1.
10
Treat to Target in Rheumatology: A Historical Account on Occasion of the 10th Anniversary.靶向治疗在风湿病学中的应用:十周年历史回顾。
Rheum Dis Clin North Am. 2019 Nov;45(4):477-485. doi: 10.1016/j.rdc.2019.07.001. Epub 2019 Aug 16.